Target intelligence / Profile preview

D-alanyl-D-alanine terminus of peptidoglycan precursors (D-Ala-D-Ala)

Target
D-Ala-D-Ala
Molecular classification
Other, Bacterial cell wall precursor
01

Overview

The D-alanyl-D-alanine (D-Ala-D-Ala) terminus of peptidoglycan precursors, specifically found on Lipid II, is a critical molecular target in bacterial cell wall biosynthesis. Lipid II is an essential, low-abundance intermediate that carries the disaccharide-pentapeptide monomer across the cytoplasmic membrane to be polymerized and cross-linked into the mature peptidoglycan mesh. The terminal D-Ala-D-Ala dipeptide serves as the substrate for bacterial transpeptidases (penicillin-binding proteins), which catalyze the cross-linking of adjacent peptidoglycan strands to provide structural integrity and prevent osmotic lysis.

This pathway is highly conserved in Gram-positive bacteria, making the D-Ala-D-Ala terminus a prime target for glycopeptide and lipoglycopeptide antibiotics. Drugs such as vancomycin, teicoplanin, and dalbavancin bind with high affinity to this terminus via hydrogen bonding, sterically hindering the transpeptidation and transglycosylation steps. This disruption weakens the cell wall, leading to bacterial cell lysis and death. However, resistance can arise when bacteria modify this target, replacing the terminal D-Ala with D-lactate or D-serine, which drastically reduces drug binding affinity.

Other names
D-alanyl-D-alanine terminus of Lipid IID-Ala-D-Ala terminus of peptidoglycan precursorsD-alanyl-D-alanineLipid II D-Ala-D-Ala terminusPeptidoglycan precursor D-Ala-D-Ala terminus
02

Mechanism of action

Inhibition of bacterial cell wall synthesis by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors, preventing transglycosylation and transpeptidation (cross-linking) of the peptidoglycan layer.

03

Biological functions

Bacterial cell wall synthesisPeptidoglycan cross-linkingTranspeptidationTransglycosylation
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityOtotoxicityRed man syndromeAntimicrobial resistance (e.g., VRE, VRSA)
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

vanA genevanB geneBacterial culture and sensitivity

Beyond the preview

Go deeper on D-alanyl-D-alanine terminus of peptidoglycan precursors (D-Ala-D-Ala).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-alanyl-D-alanine terminus of peptidoglycan precursors (D-Ala-D-Ala).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call